BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Department of Medicine - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.med.unc.edu/medicine
X-WR-CALDESC:Events for Department of Medicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20160313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20161106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170911T120000
DTEND;TZID=America/New_York:20170911T130000
DTSTAMP:20260412T101009
CREATED:20170911T160000Z
LAST-MODIFIED:20190307T190433Z
UID:10000916-1505131200-1505134800@www.med.unc.edu
SUMMARY:Cardiovascular Grand Rounds: Dr. Michael Bode\, "Protease-activated Receptors in Cardiac Disease"
DESCRIPTION:Speaker: Michael Bode\, MD. Cardiology Fellow\, UNCTopic: Protease-activated Receptors in Cardiac Disease
URL:https://www.med.unc.edu/medicine/event/cardiovascular-grand-rounds-dr-michael-bode-protease-activated-receptors-in-cardiac-disease/
CATEGORIES:Medicine Grand Rounds
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170912T140000
DTEND;TZID=America/New_York:20170912T150000
DTSTAMP:20260412T101009
CREATED:20170912T180000Z
LAST-MODIFIED:20190307T190431Z
UID:10000919-1505224800-1505228400@www.med.unc.edu
SUMMARY:McAllister Heart Institute Seminar Series: Dr. Nikolaos Frangogiannis\, "The functional pluralism of fibroblasts in the remodeling myocardium"
DESCRIPTION:Speaker: Nikolaos Frangogiannis\, MD:  Edmond J Safra/Republic National Bank of New York Professor of Cardiovascular Medicine; Professor\, Department of Medicine\, Albert Einstein College of Medicine.Topic: The functional pluralism of fibroblasts in the remodeling myocardium \nAdditional information from Dr. Frangogiannis: Cardiac fibroblast populations expand following injury and mediate repair\, while contributing to adverse remodeling and ventricular dysfunction. A growing body of evidence suggests that in addition to their matrix-secreting properties\, cardiac fibroblasts have a wide range of functions in cardioprotection\, regulation of inflammation and tissue repair. This presentation will discuss emerging concepts on the role of fibroblasts in cardiac repair\, remodeling and fibrosis.
URL:https://www.med.unc.edu/medicine/event/mcallister-heart-institute-seminar-series-dr-nikolaos-frangogiannis-the-functional-pluralism-of-fibroblasts-in-the-remodeling-myocardium/
CATEGORIES:Medicine Grand Rounds
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170914T120000
DTEND;TZID=America/New_York:20170914T130000
DTSTAMP:20260412T101009
CREATED:20170914T160000Z
LAST-MODIFIED:20190307T190429Z
UID:10000920-1505390400-1505394000@www.med.unc.edu
SUMMARY:Medicine Grand Rounds Craige Lecture\, Dr. Valentin Fuster\, "Importance of Primordial Prevention of Cardiovascular Diseases"
DESCRIPTION:Dr. Fuster is Physician-in-Chief of Mount Sinai Hospital.
URL:https://www.med.unc.edu/medicine/event/medicine-grand-rounds-craige-lecture-valentin-fuster-importance-of-primordial-prevention-of-cardiovascular-diseases/
CATEGORIES:Medicine Grand Rounds
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170914T120000
DTEND;TZID=America/New_York:20170914T130000
DTSTAMP:20260412T101009
CREATED:20170914T160000Z
LAST-MODIFIED:20190307T190427Z
UID:10000921-1505390400-1505394000@www.med.unc.edu
SUMMARY:Medicine Grand Rounds Craige Lecture\, Valentin Fuster "Importance of Primordial Prevention of Cardiovascular Diseases"
DESCRIPTION:Whereas primary prevention seeks to forestall development of disease in individuals with elevated risk\, primordial prevention seeks to preempt the development of risk factors. Health behaviors–characterized as “lifestyle” factors–are key interventional targets in primordial prevention of cardiovascular disease. Although lifestyle modification programs can be instrumental in reaching public health goals\, maintaining cardiovascular health should not be a matter solely of willpower. Ideally\, structural and social forces should make healthy lifestyles the default option. \nDr. Valentin Fuster serves The Mount Sinai Medical Hospital as Physician-in-Chief\, as well as Director of Mount Sinai Heart\, the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health. He is also the Richard Gorlin\, MD/Heart Research Foundation Professor\, Icahn School of Medicine at Mount Sinai. Dr. Fuster was the President of Science and is now the General Director of the Centro Nacional de Investigaciones Cardiovasculares Carlos III in Madrid\, Spain and also and Chairman of the Science for Health and Education Foundation. \nAmong his many achievements\, it is noteworthy that Dr. Fuster is the only cardiologist to have received the highest awards for research from the four leading cardiovascular organizations: the American Heart Association\, the American College of Cardiology\, the European Society of Cardiology and the Interamerican Society of Cardiology.
URL:https://www.med.unc.edu/medicine/event/sept-14/
CATEGORIES:Medicine Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2018/12/valentin-fuster.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170915T130000
DTEND;TZID=America/New_York:20170916T120000
DTSTAMP:20260412T101009
CREATED:20170915T170000Z
LAST-MODIFIED:20190307T190425Z
UID:10000922-1505480400-1505563200@www.med.unc.edu
SUMMARY:2017 North Carolina Cardiovascular Update Conference
DESCRIPTION:This meeting has been an annual event since 2002\, and features the Ernest & Hazel Craige Lecture. Course directors are Rick Stouffer\, MD\, and Matt Cavender\, MD. \nThis year’s lecturer/Keynote Speaker is Dr. Valentin Fuster\, MD\, PhD\, Physician in Chief\, Mount Sinai Hospital; Director of the Zena and Michael A. Wiener Cardiovascular Institute; Richard Gorlin\, MD/Heart Research Foundation Professor\, Icahn School of Medicine; Editor in Chief of JACC. \nThis conference will be focused on providing updates on advances in the treatment of patients with coronary artery disease\, peripheral vascular disease\, heart failure\, arrhythmias and valvular heart disease.  There will be panel discussions among international experts\, local opinion leaders\, and faculty from UNC. Questions will be solicited from the audience. \nLEARNING OBJECTIVES \nUpon completion of this educational activity\, the participant will be able to: \n\nIdentify and integrate various state of-the-art treatments for cardiovascular disease\, including percutaneous and surgical therapies\, by primary care physicians and cardiologists.\nReview state-of-the-art diagnostic techniques and imaging options for assessing patients with cardiovascular disease.\nReview important clinical trials in cardiology that have been completed within the past year\, including but not limited to cholesterol-lowering drugs and apply information learned to daily practice.\n\nTARGET AUDIENCE \nCardiologists\, cardiac surgeons\, internists\, family practice and primary care physicians\, emergency physicians\, nurses\, nurse practitioners\, physician assistants and other health professionals involved in the treatment of cardiovascular disease.
URL:https://www.med.unc.edu/medicine/event/2017-north-carolina-cardiovascular-update/
CATEGORIES:Medicine Grand Rounds
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170919T140000
DTEND;TZID=America/New_York:20170919T150000
DTSTAMP:20260412T101009
CREATED:20170919T180000Z
LAST-MODIFIED:20190307T190423Z
UID:10000924-1505829600-1505833200@www.med.unc.edu
SUMMARY:McAllister Heart Institute Seminar Series: Christopher Kontos\, MD\, New Insights into Skeletal Muscle-Endothelial Cell Interactions in Peripheral Artery Disease
DESCRIPTION:Speaker: Christopher Kontos\, MD. Associate Professor of Medicine\, Duke UniversityTopic: “New Insights into Skeletal Muscle-Endothelial Cell Interactions in Peripheral Artery Disease” \nPresentation Preview: Peripheral artery disease (PAD) is caused by atherosclerotic obstruction of the peripheral arteries\, most commonly the legs. The clinical manifestations of PAD include intermittent claudication\, characterized by pain with exertion that is relieved by rest\, and critical limb ischemia (CLI)\, in which patients experience rest pain with or without tissue necrosis and gangrene. Traditionally\, these different clinical presentations were thought to be due to differences in the severity of atherosclerotic vascular disease and subsequent differences in limb blood flow. However\, individuals with the same degree of vascular disease can present with vastly different phenotypes\, suggesting that genetics contribute to the different manifestations of PAD. Recent insights from our group have demonstrated that the response of skeletal muscle cells to ischemia\, independent of vascular growth or tissue perfusion\, plays an important role in determining outcomes after limb ischemia. In a mouse model of limb ischemia\, a polymorphism in BAG3 (Bcl2-associated athanogene-3) was found to play a key role in determining tissue survival vs. loss after limb ischemia\, and its potential mechanisms of action and role as a therapeutic target in PAD will be discussed. In addition\, several receptors expressed primarily on endothelial cells have been found play a role in modulating skeletal muscle cellular responses to injury\, and these receptors’ potential roles in the response to PAD and skeletal muscle differentiation will be discussed.
URL:https://www.med.unc.edu/medicine/event/mcallister-heart-institute-seminar-series-christopher-kontos-md-new-insights-into-skeletal-muscle-endothelial-cell-interactions-in-peripheral-artery-disease/
CATEGORIES:Medicine Grand Rounds
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170921T120000
DTEND;TZID=America/New_York:20170921T130000
DTSTAMP:20260412T101009
CREATED:20170921T160000Z
LAST-MODIFIED:20190307T190420Z
UID:10000925-1505995200-1505998800@www.med.unc.edu
SUMMARY:Medicine Grand Rounds\, Kenneth Ataga\, "Pharmacological Therapies for Sickle Cell Disease: Beyond Hydroxyurea"
DESCRIPTION:Dr. Ataga is the director of the UNC Comprehensive Sickle Cell Program. His clinical research is focused on the vasculopathy of sickle cell disease\, with an emphasis on pulmonary hypertension and renal complications\, and coagulation activation in sickle cell disease. \nIn addition\, he has a strong research interest in the development of new therapies for sickle cell disease. His clinical trials in sickle cell disease are funded by the National Institutes of Health and the pharmaceutical industry. Results from an international\, multicenter phase 2 clinical trial led by Dr. Ataga were published online by the New England Journal of Medicine last year\, and were presented at the annual meeting of the American Society of Hematology in San Diego. The trial found that an investigational compound called SeIG1 dramatically reduces sickle cell pain crises. \nSickle cell disease is an inherited\, blood disorder that affects one out of every 500 African-Americans. There are approximately 80\,000 people in the United States with sickle cell disease. It is also one of the most common genetic diseases\, affecting millions of people worldwide. About half of the world’s sickle cell disease population lives in three countries: Nigeria\, India and the Democratic Republic of Congo. \nPatients with sickle cell disease suffer anemia and complications in which sickle-shaped red cells and white blood cells adhere to small vessels and block blood flow to downstream organs. This vaso-occlusive process results in intense pain and repeated hospitalizations. It also leads to progressive multi-organ dysfunction and premature death.
URL:https://www.med.unc.edu/medicine/event/sept-21/
CATEGORIES:Medicine Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2018/12/kenneth-ataga.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170925T120000
DTEND;TZID=America/New_York:20170925T130000
DTSTAMP:20260412T101009
CREATED:20170925T160000Z
LAST-MODIFIED:20190307T190418Z
UID:10000926-1506340800-1506344400@www.med.unc.edu
SUMMARY:Cardiovascular Grand Rounds: David Lee\, MD. Optimal Therapies and Digital Health in Peripheral Artery Disease: There's an App for That
DESCRIPTION:Speaker: David Lee\, MD. Cardiology Fellow\, University of North CarolinaTopic: Optimal Therapies and Digital Health in Peripheral Artery Disease: There’s an App for That
URL:https://www.med.unc.edu/medicine/event/cardiovascular-grand-rounds-david-lee-md-optimal-therapies-and-digital-health-in-peripheral-artery-disease-theres-an-app-for-that/
CATEGORIES:Medicine Grand Rounds
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170928T120000
DTEND;TZID=America/New_York:20170928T130000
DTSTAMP:20260412T101009
CREATED:20170928T160000Z
LAST-MODIFIED:20190307T190416Z
UID:10000927-1506600000-1506603600@www.med.unc.edu
SUMMARY:Medicine Grand Rounds\, Sriram Machineni\, "Obesity Management: Leveraging the Heterogeneity of Response"
DESCRIPTION:Dr. Machineni is a new faculty member in Endocrinology. This lecture will cover the complexity of weight regulation\, the biological basis of heterogeneity of response to various treatments for obesity\, the role of treatment response predictors and offer a pragmatic approach to medical management of obesity. \nAt the New York Nutrition Obesity Research Center\, he conducted clinical research in diabetes and weight loss surgery. His clinical and research fellowship in Obesity Medicine and Nutrition was completed at the Massachusetts General Hospital (MGH) where he also served in the role of Assistant in Medicine\, and was an Instructor in Medicine at Harvard Medical School. His translational clinical research was aimed at finding novel therapies for obesity. Further\, Dr. Machineni is an organizing member of the Annual Blackburn course in Obesity Medicine\, which teaches physicians from around the world about the management of obesity. \nDr. Machineni served as the chief medical resident at the Buffalo General hospital and later in the roles of Director of the Primary Medicine and the Weight Management clinics. He attended medical school at the All India Institute of Medical Sciences and completed his residency in Internal Medicine from the State University of New York at Buffalo.
URL:https://www.med.unc.edu/medicine/event/sept-28/
CATEGORIES:Medicine Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2018/12/sriram-machineni.jpg
END:VEVENT
END:VCALENDAR